Band 3 is an anchor protein and a target for SHP-2 tyrosine phosphatase in human erythrocytes

Blood

Volumn 100, Issue 1, 2002, Pages 276-282

  Bordin, Luciana ^a,b   Brunati, Anna Maria ^a,b   Donella Deana, Arianna ^a,b   Baggio, Bruno ^a,b   Toninello, Antonio ^a,b   Clari, Giulio ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALPEPTIN; DIAMIDE; ERYTHROCYTE BAND 3 PROTEIN; N ETHYLMALEIMIDE; PERVANADATE; PHOSPHORUS 32; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DEPHOSPHORYLATION; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0036659906     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.1.276     Document Type: Article

References (45)

1. Low PS, Allen DP, Zioncheck TF, et al. Tyrosine phosphorylation of band 3 inhibits peripheral protein binding. J Biol Chem. 1987;262:4592-4596.
2. Harrison ML, Rathinavelu P, Arese P, Geahlen RL, Low PS. Role of band 3 tyrosine phosphorylation in the regulation of erythrocyte glycolysis. J Biol Chem. 1991;266:4106-4111.
3. Low PS, Rathinavelu P, Harrison ML. Regulation of glycolysis via reversible enzyme binding to the membrane protein band 3. J Biol Chem. 1993;268:14627-14631.
4. De Neef RS, Hardy-Dessources MD, Giraud F. Relationship between type II phosphatidylinositol 4-kinase activity and protein tyrosine phosphorylation in membranes from normal and sickle red cells. Eur J Biochem. 1996;235:549-556.
5. ++/A23187-treated human erythrocytes. Biochem J. 1996;320:445-450.
6. Mallozzi G, di Stasi AMM, Minetti M. Peroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB J. 1997;11:1281-1290.
7. De Franceschi L, Fumagalli L, Olivieri O, et al. Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. J Clin Invest. 1997;99:220-227.
8. lyn in skate erythrocytes. J Biol Chem. 1999;274:7923-7928.
9. Bordin L, Clari G, Moro I, Dalla Vecchia F, Moret V. Functional link between phosphorylation state of membrane proteins and morphological changes of human erythrocytes. Biochem Biophys Res Commun. 1995;213:249-257.
10. Minetti G, Seppi C, Ciana A, Balduini C, Low PS, Brovelli A. Characterization of the hypertonically induced tyrosine phosphorylation of erythrocyte band 3. Biochem J. 1998;335:305-311.
11. Brautigan DL. Great expectation: protein tyrosine phosphatase in cell regulation. Biochim Biophys Acta. 1992;1114:63-77.
12. Mauro LJ, Dixon JE. 'Zip codes' direct intracellular protein tyrosine phosphatases to correct cellular 'address'. Trends Biochem Sci. 1994;19:151-155.
13. Walton KM, Dixon JE. Protein tyrosine phosphatases. Annu Rev Biochem. 1993;62:101-120.
14. syk. J Biol Chem. 1994;269:955-959.
15. Zipser Y, Piade A, Kosower NS. Erythrocyte thiol status regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase. FEBS Lett. 1997;406:126-130.
16. Brunati AM, Bordin L, Clari G, et al. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes. Identification of primary and secondary phosphorylation sites. Blood. 2000;96:1550-1557.
17. Zipser Y, Kosower NS. Phosphotyrosine phosphatase associated with band 3 protein in the human erythrocyte membrane. Biochem J. 1996;314:881-887.
18. Adachi M, Fischer EH, Ihle J, et al. Mammalian SH2-containing protein tyrosine phosphatases. Cell. 1996;85:15.
19. Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 1997;9:193-204.
20. Huyer G, Alexander DR. SHP-2 docks at multiple ports. Curr Biol. 1999;9:R129-R132.
21. Tamir I, Dal Porto JM, Cambier JC. Cytoplasmic protein tyrosine phosphatase SHP-1 and SHP-2: regulators of B cell signal transduction. Curr Opin Immunol. 2000;12:307-315.
22. Unkeless JC, Jin J. Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol. 1997;9:338-343.
23. Barford D, Neel B-G. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. Structure. 1998;6:249-254.
24. Syk. Eur J Biochem. 1996;240:400-407.
25. Donella-Deana A, James P, Staudenmann W, et al. Isolation from spleen of a 57-kDa protein substrate of the tyrosine kinase Lyn. Identification as a protein related to protein disulfide-isomerase and localisation of the phosphorylation sites. Eur J Biochem. 1996;235:18-25.
26. Brunati AM, Bordin L, Clari G, Moret V. The Lyncatalyzed Tyr-phosphorylation of the transmembrane band 3 protein of human erythrocytes. Eur J Biochem. 1996;240:394-399.
27. Clari G, Brunati AM, Moret V. Partial purification and characterization of cytosolic Tyr-protein kinase(s) from human erythrocytes. Eur J Biochem. 1988;175:673-678.
28. Clari G, Brunati AM, Moret V, Partial purification and characterization of phosphotyrosyl-protein phosphatase(s) from human erythrocyte cytosol. Biochem Biophys Res Commun. 1986;137:566-572.
29. Clari G, Brunati AM, Moret V. Membrane-bound phosphotyrosyl-protein phosphatase activity in human erythrocytes: dephosphorylation of membrane band 3 protein. Biochem Biophys Res Commun. 1987;142:587-594.
30. Hanke JH, Gardner RID, Changelian PS, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem. 1996;271:695-701.
31. Neel BG. Role of phosphatases in lymphocyte activation. Curr Opin Immunol. 1997;9:405-420.
32. Huyer G, Ramachandran C. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation. Biochemistry. 1998;37:2741-2747.
33. Schoenwaelder SM, Petch LA, Williamson D, Shen R, Feng GS, Burridge K. The protein tyrosine phosphatase SHP-2 regulates RhoA activity. Curr Biol. 2000;10:1523-1526.
34. Siminovitch K, Neel B. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases. Semin Immunol. 1998;10:329-347.
35. Tonks N, Neel BG. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol. 2001;13:182-195.
36. Brunati AM, Pinna LA, Bergantino E, et al. Src homology-2 domains protect phosphotyrosyl residues against enzymatic dephosphorylation. Biochem Biophys Res Commun. 1998;243:700-705.
37. Low PS, Willardson BM, Mohandas N, Rossi M, Shohet S. Contribution of the band 3-ankyrin interaction to erythrocyte membrane mechanical stability. Blood. 1991;77:1581-1586.
38. Peters LL, Shivdasani RA, Liu SC, et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell. 1996;86:917-927.
39. Southgate CD, Chishti AH, Mitchell B, Yi SJ, Palek J. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nat Genet. 1996;14:227-230.
40. Jennings ML, Passow H. Anion transport across the erythrocyte membrane, in situ proteolysis of band 3 protein, and cross-linking of proteolytic fragments by 4,4′-diisothiocyano dihydrostilbene-2,2′-disulfonate. Biochim Biophys Acta. 1979;554:498-519.
41. Wang DN. Band 3 protein: structure, flexibility and function. FEBS Lett. 1994;346:26-31.
42. Kannan R, Yuan J, Low PS. Isolation and partial characterization of antibody- and globin-enriched complexes from membranes of dense human erythrocytes. Biochem J. 1991;278:57-62.
43. Zhang D, Kiyatkin A, Bolin JT, Low PS. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Blood. 2000;96:2925-2933.
44. 2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: a study using an inhibitor for scramblase that mimics the defect in Scott syndrome. Blood. 1998;91:2133-2138.
45. Terra HTMB, Saad MJA, Carvalho CRO, Vicentin DL, Costa FF, Saad STO. Increased tyrosine phosphorylation of band 3 in hemoglobinopathies. Am J Hematol. 1998;58:224-230.